siRNA, Anti-TRIP10, 2'-F/2'-OMe/2'-MOE/Ribo/Backbone-modified(CAT#: SIRGT26929WQ-2OMe)

The product SIRGT26929WQ-2OMe is a type of small interfering RNA (siRNA) that targets TRIP10 gene and regulates the expression of gene. The siRNA interferes with the expression of TRIP10 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001288962.1; NM_001288963.1; NM_004240.3
Alternative Names CIP4; HSTP; STOT; STP; TRIP-10
Related Diseases Wiskott-Aldrich Syndrome
Purification HPLC
Target Gene
Gene ID 9322
Uniprot ID Q15642
Sub Cat Target Species Modification Scale  
SIRGT27929WQ-2F TRIP10 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT28929WQ-2MOE TRIP10 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT82230WQ-2F Trip10 Mouse 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT83230WQ-2MOE Trip10 Mouse 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT26929WQ-RB TRIP10 Human Ribo-modified Inquiry
SIRGT81230WQ-RB Trip10 Mouse Ribo-modified Inquiry
SIRGT27929WQ-BB TRIP10 Human Backbone-modified Inquiry
SIRGT82230WQ-BB Trip10 Mouse Backbone-modified Inquiry

Related Products